Estimados colegas:
Tal y como hemos realizado con congresos previos, a lo largo de la celebración del Congreso del American College of Cardiology 2015 (San Diego, del 14 al 16 de marzo) comentaremos en el blog de Revista Española de Cardiología las sesiones denominadas Late-Breaking Clinical Trials.
En concreto, nos centraremos en las siguientes sesiones:
ACC.15 Opening Showcase and the Joint ACC/JACC Late-Breaking Clinical Trials
Sábado 14 de Marzo
A Randomized Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial
Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) -Thrombolysis in Myocardial Infarction (TIMI) 54
Joint ACC/JAMA Late-Breaking Clinical Trials
Domingo 15 de Marzo
Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes (OSLER 1 and 2)
The EMBRACE STEMI Study: A Phase 2a, Randomized, Double-Blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia™ on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction (EMBRACE STEMI)
A Randomized, Open-label, Multi-center, Active-controlled, Parallel Group Study to Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention (REGULATE-PCI)
Computed Tomography Coronary Angiography in Patients With Suspected Angina Due to Coronary Heart Disease (The SCOT-HEART Trial)
Economic Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected CAD: Results From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial
Late-Breaking Clinical Trials III
Domingo 15 de Marzo
Five-year Outcomes After Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of the PARTNER 1 Trial
A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes (CoreValve US Pivotal High Risk Trial)
Early Clinical and Echocardiographic Outcomes With the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-risk and Intermediate-risk Aortic Stenosis Patients
First Report of the DEFLECT III Trial Results: A Prospective Randomized Evaluation of the TriGuardTM HDH Embolic Deflection Device During Transcatheter Aortic Valve Replacement
Outcomes of the Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States
Joint ACC/New England Journal of Medicine Late-Breaking Clinical Trials
Lunes, 16 de Marzo
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial
Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
Long-term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-year Follow-up Study (LEGACY Study)
Everolimus-eluting Stents versus Bypass Surgery for Multivessel Coronary Artery Disease (BEST)
Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Multi-center Randomized Controlled Clinical Trial (ERRICA)